DrugPatentWatch - Biopharmaceutical Business Intelligence
Profile for INC Research Holdings, Inc. (INCR)
« Back to company indexINCR Chatter Timeline
Stock Ticker for INCR
Most Active Tweeters for INCR
| User | Tweets |
|---|---|
| @marketexclusive | 2 |
| @Stock_News_Now | 1 |
Recent Tweets for INCR
 |
@Stock_News_Now $INCR: New SEC Filing for INCR: Form 10-K (No. 0001610950-19-000008): https://t.co/C87b1E4PMH March 18th 2019, 4:03pm |
 |
@marketexclusive $INCR Inc. (NASDAQ:INCR) Files An 8-K Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year https://t.co/2NjICxmlDK March 16th 2019, 3:03am |
|
@marketexclusive $INCR Inc. (NASDAQ:INCR) Files An 8-K Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year https://t.co/YOeBdA3wtc March 15th 2019, 5:03pm |
|
@marketexclusive $INCR Inc. (NASDAQ:INCR) Files An 8-K Results of Operations and Financial Condition https://t.co/mJhtGUzvK4 March 4th 2019, 8:03am |
 |
@confcalltran INC Research Holdings, Inc.'s Chief Financial Officer just disposed of 2,617 shares https://t.co/CKCw7SRhnd $INCR February 19th 2019, 4:02pm |
|
@confcalltran INC Research Holdings, Inc.'s Chief Executive Officer just disposed of 12,451 shares https://t.co/dtii9ZiMJT $INCR February 19th 2019, 4:02pm |
 |
@israeli_bulls $INCR the bull pattern is confirmed & a BUY signal is issued @ https://t.co/7Ngc6xXNTt. Buy Level: 1187.0000 Target: 1388.79 February 18th 2019, 11:02am |
|
@israeli_bulls $INCR may go up 17% if the bull pattern is confirmed. Chk confirmation [20%] @ https://t.co/7Ngc6xXNTt. Buy level:1161.0000. February 17th 2019, 11:02am |
 |
@StockTexts $INCR INC Research Holdings, Inc. SEC Filing: Form 4 https://t.co/ffKtXDa96H February 15th 2019, 7:02am |
|
@confcalltran INC Research Holdings, Inc.'s Chief Executive Officer just cashed-in 8,143 options https://t.co/IhZ79fndYJ $INCR February 15th 2019, 7:02am |
|
@marketexclusive $INCR Inc. (NASDAQ:INCR) Files An 8-K Entry into a Material Definitive Agreement https://t.co/mafpRs0EiR February 14th 2019, 8:02am |
|
@Stock_News_Now $INCR: New SEC Filing for INCR: Form SC 13G/A (No. 0000932471-19-006163): https://t.co/LjmtsS3CyF February 13th 2019, 10:02am |
|
@confcalltran The Vanguard Group just provided an update on share ownership of INC Research Holdings, Inc. https://t.co/58dZs6juWK $INCR February 13th 2019, 10:02am |
|
@StockTexts $INCR INC Research Holdings, Inc. SEC Filing: Form SC 13G/A https://t.co/17SsfvL9SY February 13th 2019, 10:02am |
|
@StockTexts $INCR INC Research Holdings, Inc. SEC Filing: Form 3 https://t.co/laYhwlLdIR February 8th 2019, 4:02pm |
|
@StockTexts $INCR INC Research Holdings, Inc. SEC Filing: Form 4 https://t.co/uGjAx7hpt6 February 7th 2019, 8:02am |
|
@israeli_bulls $INCR the bull pattern is confirmed & a BUY signal is issued @ https://t.co/7Ngc6xXNTt. Buy Level: 1047.5200 Target: 2419.77 February 5th 2019, 11:02am |
 |
@StockTipRobot New Wikileaks docs say now is the time to sell INC Research $INCR #InvestingTip February 4th 2019, 12:02pm |
|
@israeli_bulls $INCR may go up 131% if the bull pattern is confirmed. Chk confirmation [20%] @ https://t.co/7Ngc6xXNTt. Buy level:1030.0000. February 4th 2019, 11:02am |
|
@Stock_News_Now $INCR: New SEC Filing for INCR: Form 8-K (No. 0001193125-19-025885): https://t.co/2ce8l2gw9P February 1st 2019, 4:02pm |
|
@StockTexts $INCR INC Research Holdings, Inc. SEC Filing: Form 4 https://t.co/nXHLdLGhFL January 23rd 2019, 4:01pm |
|
@Stock_News_Now $INCR: New SEC Filing for INCR: Form 8-K (No. 0001193125-19-005465): https://t.co/hJT60Qm4eX January 10th 2019, 6:01am |
|
@marketexclusive $INCR Inc. (NASDAQ:INCR) Files An 8-K Entry into a Material Definitive Agreement https://t.co/anq6uzVm06 December 31st 2018, 8:12am |
|
@marketexclusive $INCR Inc. (NASDAQ:INCR) Files An 8-K Entry into a Material Definitive Agreement https://t.co/UJQU4ybi3Q December 30th 2018, 1:12pm |
|
@marketexclusive $INCR Inc. (NASDAQ:INCR) Files An 8-K Entry into a Material Definitive Agreement https://t.co/vtTGMF7JpF December 28th 2018, 5:12pm |
DrugPatentWatch - Make Better Decisions
Contact © thinkBiotech LLC
2004 - 2019. All rights reserved.